Search results
Results from the Go Local Guru Content Network
MYmta is a mobile application-based passenger information display system developed by the Metropolitan Transportation Authority (MTA) of New York City. A beta version of the app was launched on July 2, 2018, and as of June 2019 [update] is still undergoing beta testing .
The Metropolitan Transportation Authority (MTA) said its new MTA app is available for download. The app is still in Beta testing, but will eventually succeed the MYmta app.
The Metropolitan Transportation Authority (MTA) provides local and express bus, subway, and commuter rail service in Greater New York, and operates multiple toll bridges and tunnels in New York City. The Metropolitan Transportation Authority ( MTA) is a public benefit corporation responsible for public transportation in the New York City ...
β adrenergic receptor antagonists (also called beta-blockers or β-blockers) were initially developed in the 1960s, for the treatment of angina pectoris but are now also used for hypertension, congestive heart failure and certain arrhythmias.
The cellphone-friendly website and "MYmta" app, currently in a beta test phase, show straphangers real-time subway, bus and commuter rail information that has been housed in separate apps.
Beta blockers, also spelled β-blockers, are a class of medications that are predominantly used to manage abnormal heart rhythms , and to protect the heart from a second heart attack after a first heart attack (secondary prevention).
MTA Regional Bus Operations bus fleet. The MTA Regional Bus Operations bus fleet is a fleet of buses in fixed-route service in New York City under the "MTA New York City Bus" (also known as New York City Transit or NYCT) and "MTA Bus" brands, both of which operate local, limited, express and Select Bus Service routes.
Non-selective beta blocker: Migraine prophylaxis: APO-PROPRANOLOL: Timolol: Non-selective beta blocker: Glaucoma and ocular hypertension: APO-DORZO-TIMOP: Atenolol: Selective beta-1 blocker: Hypertension, angina and acute myocardial infarction: ALONET: Metoprolol: Selective beta-1 blocker
The beta-1 adrenergic receptor (β 1 adrenoceptor), also known as ADRB1, can refer to either the protein-encoding gene (gene ADRB1) or one of the four adrenergic receptors. [5] It is a G-protein coupled receptor associated with the Gs heterotrimeric G-protein that is expressed predominantly in cardiac tissue.
Metoprolol is a beta blocker, or an antagonist of the β-adrenergic receptors. It is specifically a selective antagonist of the β 1-adrenergic receptor and has no intrinsic sympathomimetic activity. Metoprolol exerts its effects by blocking the action of certain neurotransmitters, specifically adrenaline and noradrenaline.